论文部分内容阅读
原发性精囊腺癌是一种极其罕见的恶性肿瘤,目前尚无统一的诊治标准,应与前列腺癌、直肠癌、膀胱癌等相鉴别。完整切除肿瘤是较公认的治疗方法之一,因早期缺乏特异性临床表现且极其罕见,故发现时多为晚期,预后较差。2012年7月华中科技大学同济医学院附属同济医院收治1例精囊腺癌患者,年龄51岁,患者行局部切除术,术后有肉眼肿瘤残留,术后病理为原发性精囊腺癌。术后采用紫杉醇(175 mg/m2)联合顺铂(60 mg/m2)6个疗程的化疗方案,静脉滴注,盆腔局部行60 Gy/30次适形放疗,取得一定疗效,目前患者定期随访。
Primary seminal vesicle adenocarcinoma is an extremely rare malignancy, there is no unified diagnosis and treatment standards, should be with prostate cancer, rectal cancer, bladder cancer, etc. phase identification. Complete resection of the tumor is more recognized as one of the treatment methods, due to the early lack of specific clinical manifestations and extremely rare, it was found mostly late, the prognosis is poor. July 2012 Huazhong University of Science and Technology Tongji Medical College Affiliated Tongji Hospital 1 patient with seminal vesicle adenocarcinoma, aged 51 years, underwent partial resection and had residual tumor after operation. The pathology of the patient was primary seminal vesicle adenocarcinoma. Postoperative chemotherapy with paclitaxel (175 mg / m2) combined with cisplatin (60 mg / m2) 6 courses of chemotherapy, intravenous drip, pelvic local line 60 Gy / 30 conformal radiotherapy, and achieved some effect, the current regular follow-up .